| Primary |
| Drug Use For Unknown Indication |
26.5% |
| Product Used For Unknown Indication |
25.3% |
| Hypertension |
16.9% |
| Atrial Fibrillation |
7.8% |
| Suicide Attempt |
4.5% |
| Angina Pectoris |
2.7% |
| Blood Pressure Increased |
2.6% |
| Blood Pressure |
2.2% |
| Completed Suicide |
1.5% |
| Intentional Overdose |
1.2% |
| Induction Of Anaesthesia |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
| Overdose |
0.9% |
| Prinzmetal Angina |
0.9% |
| Tachycardia |
0.9% |
| Anaesthesia |
0.8% |
| Atrial Flutter |
0.8% |
| Bacterial Infection |
0.8% |
| Colon Cancer |
0.8% |
|
| Poisoning |
16.1% |
| Completed Suicide |
10.8% |
| Respiratory Arrest |
8.6% |
| Drug Interaction |
5.9% |
| Hypotension |
5.9% |
| Acute Generalised Exanthematous Pustulosis |
4.3% |
| Blood Pressure Increased |
4.3% |
| Bradycardia |
3.8% |
| Cardiac Arrest |
3.8% |
| Medication Error |
3.8% |
| Overdose |
3.8% |
| Sinus Bradycardia |
3.8% |
| Skin Test Positive |
3.8% |
| Dizziness |
3.2% |
| Product Substitution Issue |
3.2% |
| Toxicity To Various Agents |
3.2% |
| Vision Blurred |
3.2% |
| Vomiting |
3.2% |
| Dyspnoea |
2.7% |
| Rash |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
40.2% |
| Hypertension |
15.6% |
| Drug Use For Unknown Indication |
12.2% |
| Atrial Fibrillation |
5.4% |
| Polyuria |
3.7% |
| Blood Pressure |
3.6% |
| Migraine |
2.6% |
| Completed Suicide |
2.1% |
| Angina Pectoris |
1.5% |
| Cardiac Failure |
1.5% |
| Arrhythmia |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Pulmonary Arterial Hypertension |
1.3% |
| Asthma |
1.2% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Cardiac Disorder |
1.2% |
| Pain |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Diabetes Mellitus |
1.1% |
| Blood Cholesterol Increased |
0.9% |
|
| Completed Suicide |
28.9% |
| Dizziness |
6.4% |
| Vision Blurred |
4.9% |
| Drug Hypersensitivity |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Cardio-respiratory Arrest |
3.8% |
| Cardiogenic Shock |
3.8% |
| Death |
3.8% |
| Sepsis |
3.8% |
| Somnolence |
3.8% |
| Blood Pressure Increased |
3.4% |
| Overdose |
3.4% |
| Renal Failure Acute |
3.4% |
| Respiratory Arrest |
3.4% |
| Vertigo |
3.4% |
| Cardiac Arrest |
3.0% |
| Colitis Ischaemic |
3.0% |
| Drug Toxicity |
3.0% |
| Pleural Effusion |
3.0% |
| Syncope |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.0% |
| Drug Use For Unknown Indication |
19.8% |
| Hypertension |
14.3% |
| Atrial Fibrillation |
7.5% |
| Pain |
3.8% |
| Diabetes Mellitus |
3.8% |
| Rheumatoid Arthritis |
3.2% |
| Prophylaxis |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Asthma |
2.7% |
| Angina Pectoris |
2.5% |
| Depression |
2.2% |
| Cardiac Disorder |
1.9% |
| Osteoporosis |
1.9% |
| Blood Cholesterol Increased |
1.8% |
| Multiple Myeloma |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Type 2 Diabetes Mellitus |
1.5% |
| Blood Pressure |
1.5% |
| Anxiety |
1.4% |
|
| Vomiting |
13.7% |
| Weight Decreased |
7.4% |
| Dyspnoea |
7.0% |
| Death |
6.1% |
| Pneumonia |
5.3% |
| Dehydration |
4.9% |
| Renal Failure Acute |
4.8% |
| Nausea |
4.4% |
| Weight Increased |
4.4% |
| Interstitial Lung Disease |
4.3% |
| Urinary Tract Infection |
4.3% |
| International Normalised Ratio Increased |
4.2% |
| Renal Failure |
4.1% |
| Sepsis |
4.1% |
| Drug Ineffective |
3.6% |
| Respiratory Failure |
3.6% |
| Thrombocytopenia |
3.6% |
| Pain |
3.5% |
| Hypotension |
3.4% |
| Myocardial Infarction |
3.4% |
|
| Interacting |
| Hypertension |
27.0% |
| Product Used For Unknown Indication |
11.4% |
| Induction Of Anaesthesia |
10.9% |
| Tachycardia |
8.1% |
| Subarachnoid Haemorrhage |
6.6% |
| Atrial Fibrillation |
5.2% |
| Drug Use For Unknown Indication |
3.3% |
| Maintenance Of Anaesthesia |
3.3% |
| Prophylaxis |
3.3% |
| Atrial Flutter |
2.8% |
| Cardiac Failure |
2.4% |
| Hiv Infection |
2.4% |
| Sedation |
2.4% |
| Blood Cholesterol Increased |
1.9% |
| Ischaemic Cardiomyopathy |
1.9% |
| Angina Pectoris |
1.4% |
| Anxiety |
1.4% |
| Arrhythmia |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
|
| Drug Interaction |
20.0% |
| Hypotension |
10.0% |
| Tibia Fracture |
8.0% |
| Cardiac Arrest |
6.0% |
| Electrocardiogram Qt Prolonged |
6.0% |
| Hyperkalaemia |
6.0% |
| Gastrointestinal Disorder |
4.0% |
| Loss Of Consciousness |
4.0% |
| Myalgia |
4.0% |
| Overdose |
4.0% |
| Pain |
4.0% |
| Sinus Arrest |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Tremor |
4.0% |
| Arterial Stent Insertion |
2.0% |
| Atrioventricular Block Complete |
2.0% |
| Bradycardia |
2.0% |
| Cardio-respiratory Arrest |
2.0% |
| Convulsion |
2.0% |
| Diarrhoea |
2.0% |
|
